Market Overview:

The global vaccine storage and packaging market size reached US$ 25.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 44.1 Billion by 2027, exhibiting a growth rate (CAGR) of 9.6% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Vaccine storage and packaging refer to various laboratory devices and equipment used to preserve, store and transport vaccines. Some of the commonly used vaccine storage equipment includes refrigerators and freezers that store vaccine vials, ampoules and corrugated boxes. The vaccines are packed and stored in individual containers and bundled together in cold boxes and carriers under cold chain facilities that regulate and maintain the desired internal temperature for ensuring safe transportation of the product. As a result, they find extensive applications across blood banks, hospitals, laboratories, pharmacies and other healthcare centers.

The increasing prevalence of various viral infections and immunological disorders across the globe represents one of the key factors driving the growth of the market. With the onset of the coronavirus disease (COVID-19), there is a significant increase in the requirement for efficient vaccine storage and packaging facilities. Furthermore, rising awareness regarding the early diagnosis and prevention of infectious diseases has enhanced the demand for protective vaccines, is also driving the market growth. Additionally, various technological advancements, such as the development of innovative cold chain facilities with minimal risks of vaccine freezing and improved quality control, are acting as other growth-inducing factors. In line with this, the market is also driven by the implementation of favorable government policies to promote various immunization programs and to optimize the production, storage and distribution of vaccines. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global vaccine storage and packaging market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on segment, vaccine storage breakup by segment, vaccine packaging breakup by type and end user.

Breakup by Segment:

• Vaccine Storage
• Vaccine Packaging
   

Vaccine Storage Breakup by Segment:

• Storage Equipment
  • Refrigerators
  • Freezers
  • Others
• Service
  • Warehouse Storage Services
  • Transportation Services
     

Vaccine Packaging Breakup by Type:

• Packaging Type
  • Vaccine Cool Bags, Vials and Ampoules
  • Corrugated Boxes
  • Others
• Packaging Level
  • Primary
  • Secondary
  • Tertiary
     

Breakup by End User:

• Biopharmaceutical Companies
• Hospitals
• Medical Laboratories
• Others 
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AmerisourceBergen Corporation, Arctiko A/S, Cardinal Logistics Management Corporation, DHL International GmbH (The Deutsche Post AG), Lineage Logistics LLC, McKesson Corporation, Nipro Corporation, PHC Holdings Corporation, Schenker Aktiengesellschaft and Thermo Fisher Scientific Inc.

Report Coverage: